- Title:
- Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
- Authors:
- Source:
- Virchows Archiv: European Journal of Pathology. 484(1):3-14
Academic Journal
Dear user, the application need JavaScript support. Please enable JavaScript in your browser.